deltatrials
Recruiting PHASE1 INTERVENTIONAL 1-arm NCT06235125

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children (Cytalux)

A Pilot Study of Near-Infrared Imaging Using the Novel Imaging Agent Cytalux for Adolescent Patients With Metastatic Osteosarcoma Undergoing Pulmonary Metastasectomy

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Conditions Fluorescence Metastatic Sarcoma Osteosarcoma Pediatrics Pulmonary Metastasis
Interventions Cytalux
Updated 3 times since 2024 Last updated: Aug 20, 2024 Started: Apr 8, 2024 Primary completion: Jan 20, 2026 Completion: Jan 20, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Fluorescence and Metastatic Sarcoma and is currently actively recruiting participants. Ann & Robert H Lurie Children's Hospital of Chicago leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE1

  3. Feb 2024 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ann & Robert H Lurie Children's Hospital of Chicago
  • On Target Laboratories, LLC
Data source: Ann & Robert H Lurie Children's Hospital of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations